These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29302376)

  • 21. Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Ann Diagn Pathol; 2021 Feb; 50():151677. PubMed ID: 33310591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
    Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
    World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation.
    Najafi M; Kordi-Tamandani DM; Arish M
    J Ophthalmol; 2016; 2016():5431021. PubMed ID: 26942001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
    Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
    Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.
    Suh JH; Won KY; Kim GY; Bae GE; Lim SJ; Sung JY; Park YK; Kim YW; Lee J
    Int J Clin Exp Pathol; 2015; 8(11):14608-18. PubMed ID: 26823784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancer.
    Lin XY; Zhang XP; Wu JH; Qiu XS; Wang EH
    Tumour Biol; 2014 Jul; 35(7):6435-43. PubMed ID: 24682895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.
    Jiang Z; Li X; Hu J; Zhou W; Jiang Y; Li G; Lu D
    Neurosci Res; 2006 Dec; 56(4):450-8. PubMed ID: 17049657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
    Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
    Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer.
    Du CY; Chen JG; Zhou Y; Zhao GF; Fu H; Zhou XK; Shi YQ
    World J Gastroenterol; 2012 Jul; 18(27):3610-6. PubMed ID: 22826628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma.
    Jang SH; Oh MH; Cho H; Lee JH; Lee H; Ahn H; Kim H
    Pol J Pathol; 2019; 70(3):189-197. PubMed ID: 31820862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anatomical location-based nodal staging system is superior to the 7th edition of the American Joint Committee on Cancer staging system among patients with surgically resected, histologically low-grade gastric cancer: A single institutional experience.
    Chen MW; Chan CP; Lin YJ; Yen HH
    PLoS One; 2019; 14(2):e0211836. PubMed ID: 30721261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased expression levels of DAL-1 and TOB1 are associated with clinicopathological features and poor prognosis in gastric cancer.
    Guo H; Zhang R; Afrifa J; Wang Y; Yu J
    Pathol Res Pract; 2019 Jun; 215(6):152403. PubMed ID: 30962003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state.
    Furth N; Pateras IS; Rotkopf R; Vlachou V; Rivkin I; Schmitt I; Bakaev D; Gershoni A; Ainbinder E; Leshkowitz D; Johnson RL; Gorgoulis VG; Oren M; Aylon Y
    Life Sci Alliance; 2018 Oct; 1(5):e201800171. PubMed ID: 30456386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
    Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
    World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
    Tang C; Gao X; Liu H; Jiang T; Zhai X
    Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of LATS1 and LATS2 promoter methylation in OSCC development.
    Ladiz MA; Najafi M; Kordi-Tamandani DM
    J Cell Commun Signal; 2017 Mar; 11(1):49-55. PubMed ID: 27761802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for a tumor suppressor role for the large tumor suppressor genes LATS1 and LATS2 in human cancer.
    Yu T; Bachman J; Lai ZC
    Genetics; 2013 Nov; 195(3):1193-6. PubMed ID: 24026096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer.
    Deng H; Wu RL; Zhou HY; Huang X; Chen Y; Liu LJ
    World J Gastroenterol; 2006 Feb; 12(7):1013-7. PubMed ID: 16534839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.